Exact Sciences has been redefining the landscape of cancer detection and treatment. Established in 1995 and headquartered in the United States, the company has built a reputation for its innovative approach toward healthcare.
Under the slogan, "Changing the way we think about detecting and treating cancer," Exact Sciences has been charting a new course in cancer diagnostics. Recently, the company was acquired by healthcare giant Abbott, a significant move that aims to harness shared resources and expertise. With this acquisition valued at $21.00B, finalized on 01 November 2025, Exact Sciences is now primed to make a broader global impact.
Abbott, known for its comprehensive portfolio that includes diagnostics, medical devices, and nutritional products, plans to integrate Exact Sciences’ capabilities to further revolutionize healthcare delivery. Through this strategic partnership, the unified entity continues to focus on enhancing global health, serving over 160 countries with a workforce of 122,000 dedicated professionals.